Staphylococcal septic arthritis: Antibiotic and nonsteroidal anti- inflammatory drug treatment in a rabbit model

Journal of Orthopaedic Research

Volumn 15, Issue 6, 1997, Pages 919-926

  Smith, R L ^a   Kajiyama, G ^a   Schurman, D J ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTICS; COLLAGEN; DRUG THERAPY; PHYSIOLOGICAL MODELS;

GLYCOSAMINOGLYCAN; STAPHYLOCOCCAL SEPTIC ARTHRITIS;

CARTILAGE;

ANTIBIOTIC AGENT; CEFTRIAXONE; COLLAGEN; DICLOXACILLIN; GLYCOSAMINOGLYCAN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN E2;

ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC THERAPY; ARTICLE; ARTICULAR CARTILAGE; BACTERIAL ARTHRITIS; CARTILAGE DEGENERATION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFECT; FEMALE; INTRAMUSCULAR DRUG ADMINISTRATION; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RABBIT; STAPHYLOCOCCUS AUREUS;

EID: 0031277980     PISSN: 07360266     EISSN: None     Source Type: Journal    
DOI: 10.1002/jor.1100150619     Document Type: Article

References (41)

1. 1 Abdelnour A, Bremell T, Holmdahl R, Tarkowski A: Role of T lymphocytes in experimental Staphylococcus aureus arthritis. Scand J Immunol 39: 403–408, 1994
2. 2 Bennett OM. Namnyak SS: Acute septic arthritis of the hip joint in infancy and childhood. Clin Orthop 281: 123–132, 1992
3. 3 Bohach GA. Fast DJ. Nelson RD. Schlievert PM: Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses. Crit Rev Microbiol 17: 251–272, 1990
4. 4 Bremell T, Lange S, Yacoub A, Ryden C, Tarkowski A: Experimental Staphylococcus aureus arthritis in mice. Infect Immun 59: 2615–2623, 1991
5. 5 Bremell T, Abdelnour A, Tarkowski A: Histopathological and serological progression of experimental. Staphylococcus aureus arthritis. Infect Immun 60: 2976–2985, 1992
6. 6 Choi IR, Pizzutillo PD, Bowen JR, Dragann R, Malhis T: Sequelae and reconstruction alter septic arthritis of the hip in infants. J Bone Joint Surg [Am] 72: 1150–1165, 1990
7. 7 Curtiss PH Jr, Klein LC: Destruction of articular cartilage in septic arthritis. I. In vitro studies. J Bone Joint Surg [Am] 45: 797–806, 1963
8. 8 Curtiss PH Jr, Klein LC: Destruction of articular cartilage in septic arthritis. II. In vivo studies. J Bone Joint Surg [Am] 47: 1595–1604, 1965
9. 9 Daniel D, Boyer J, Green S, Amiel D, Akeson W: Cartilage destruction in experimentally produced Staphylococcus aureus joint infections: in vivo study. Surg Forum 24: 479–481, 1973
10. 10 Daum RS, Davis WH, Farris KB, Campeau RJ, Mulvihill DM, Shane SM: A model of Staphylococcus aureus bacteremia, septic arthritis, and osteomyelitis in chickens. J Orthop Res 8: 804–813, 1990
11. 11 Dubost JJ, Fis I, Denis P, Lopitaux R, Soubrier M, Ristori JM, Bussiere JL. Sirot J, Sauvezie B: Polyarticular septic arthritis. Medicine 72: 296–310, 1993
12. 12 Esterhai JL Jr, Gelb I: Adult septic arthritis. Orthop Clin North Am 22: 503–514, 1991
13. 13 Goldenberg DL, Reed Jl: Bacterial arthritis. New Engl J Med 312: 764–771, 1985
14. 14 Goldenberg DL: Infectious arthritis complicating rheumatoid arthritis and other chronic rheumatic disorders. Arthritis Rheum 32: 496–502, 1989
15. 15 Goldenberg DL: Septic arthritis and other infections of rheumatologic significance. Rheum Dis Clin North Am 17: 149–156, 1991
16. 16 Jacobson MA, Gellerman H, Chambers H: Staphylococcus aureus bacteremia and recurrent staphylococcal infection in patients with acquired immunodeficiency syndrome and AlDS‐related complex. Am J Med 85: 172–176, 1988
17. 17 Jerosch J, Hoffstetter I, Schroder M, Castro WH: Septic arthritis: arthroscopic management with local antibiotic treatment. Acta Orthop Belg 61: 126–134, 1995
18. 18 Lane NE, Williams RJ III, Schurman DJ, Smith RL: Inhibition of interleukin 1 induced chondrocyte protease activity by a corticosteroid and a nonsteroidal antiinflammatory drug. J Rheumatol 19: 135–139, 1992
19. 19 Leighty SM, Spach DH, Myall RW, Burns JL: Septic arthritis of the temporomandibular joint: review of the literature and report of two cases in children. Int J Oral Maxillofac Surg 22: 292–297, 1993
20. 20 Mateo Soria L, Miquel Nolla Sole J, Rozadilla Sacanell A, Valverde Garcia J, Roig Escofet D: Infectious arthritis in patients with rheumatoid arthritis. Ann Rheum Dis 51: 402–403, 1992
21. 21 Mikhail IS, Alarcon GS: Nongonococcal bacterial arthritis. Rheum Dis Clin North Am 19: 311–331, 1993
22. 22 Musher DM, Lamm N, Darouiche RO, Young EJ, Ramill RJ, Landon GC: The current spectrum of Staphylococcus aureus infection in a tertiary care hospital. Medicine 73: 186–208, 1994
23. 23 Nord KD, Dore DD, Deeney VF, Armstrong AL, Cundy PJ. Cole BF, Ehrlich MG: Evaluation of treatment modalities for septic arthritis with histological grading and analysis of levels of uronic acid, neutral protease, and interleukin‐1. J Bone Joint Surg [Am] 77: 258–265, 1995
24. 24 Ostensson A, Geborek P: Septic arthritis as a non‐surgical complication in rheumatoid arthritis: relation to disease severity and therapy. Br J Rheumatol 30: 35–38, 1991
25. 25 Patti JM, Bremell T, Krajewska‐Pietrasik D, Abdelnour A, Tarkowski A, Ryden C, Hook M: The staphylococcus aureus collagen adhesin is a virulence determinant in experimental septic arthritis. Infect Immun 62: 152–161, 1994
26. 26 Peters RH, Rasker JI, Jacobs JW, Prevo RL, Karthaus RJ: Bacterial arthritis in a district hospital. Clin Rheumatol 11: 351–355, 1992
27. 27 Riegels‐Nielsen P, Frimodt‐Moller N, Sorensen M, Jensen JS: Antibiotic treatment insufficient for established septic arthritis: Staphyloccus aureus experiments in rabbits. Acta Orthop Scand 60: 113–115, 1989
28. 28 Riegels‐Nielsen P, Frimodt‐Moller N, Sorensen M, Jensen JS: Synovectomy for septic arthritis: early versus late synovectomy studied in the rabbit knee. Acta Orthop Scand 62: 315–318, 1991
29. 29 Rivera J, Monteagudo I, Lopez‐Longo J, Sanchez‐Atrio A: Septic arthritis in patients with acquired immunodeficiency syndrome with human immunodeficiency virus infection J Rheumatol 19: 1960–1962, 1992
30. 30 Schurman DJ, Smith RL: Surgical approach to management of septic arthritis. Orthop Rev 16: 241–245, 1987
31. 31 Smith RL, Merchant TC, Schurman DJ: In vitro cartilage degradation by Escherichia coli and Staphylococcus aureus Arthritis Rheum 25: 441–446, 1982
32. 32 Smith RL, Schurman DJ, Comparison of cartilage destruction between infectious and adjuvant arthritis. J Orthop Res 1: 136–143, 1983
33. 33 Smith RL, Schurman DJ, Bacterial Arthritis: A staphylococcal proteoglycan‐releasing factor. Arthritis Rheum 29: 1378–1386, 1986
34. 34 Smith RL, Schurman DJ, Kajiyama G, Mell M, Gilkerson E: The effect of antibiotics on the destruction of cartilage in experimental infectious arthritis. J Bone Joint Surg [Am] 69: 1063–1068, 1987
35. 35 Smith RL, Schurman DJ, Kajiyama G, Sarossy J: Effect of NSAID and antibiotic treatment in a rabbit model of staphylococcal infectious arthritis. Trans Orthop Res Soc 5: 296, 1990
36. 36 Smith RL, Kajiyama GK, Lane NE: Nonsteroidal antiinflammatory drugs: effects on normal and interleukin 1 treated human articular chondrocyte metabolism in vitro. J Rheumatol 22: 1130–1137, 1995
37. 37 Studahl M, Bergman B, Kalebo P, Lindberg J: Septic arthritis of the knee: a 10‐year review and long‐term follow‐up using a new scoring system, Scand J Infect Dis 26: 85–93, 1994
38. 38 Switalski LM, Patti JM, Butcher W, Gristina AG, Speziale P, Hook M: A collagen receptor on Staphylococcus aureus strains isolated from patients with septic arthritis mediates adhesion to cartilage. Mol Microbiol 7: 99–107, 1993
39. 39 Williams RJ III, Smith RL, Schurman DJ: Septic arthritis: staphylococcal induction of chondrocyte proteolytic activity. Arthritis Rheum 33: 533–541, 1990
40. 40 Williams RJ III, Smith RL, Schurman DJ: Purified staphylococcal culture medium stimulates neutral metalloprotease secretion from human articular cartilage. J Orthop Res 9: 258–265, 1991
41. 41 Youssef PP, York JR: Septic arthritis: a second decade of experience. Aust N Z J Med 24: 307–311, 1994